peptide elongation factor 2 has been researched along with paclitaxel in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González, VM; Hernández-Jiménez, M; Martín, ME; Piñeiro, D; Salinas, M | 1 |
1 other study(ies) available for peptide elongation factor 2 and paclitaxel
Article | Year |
---|---|
Translation regulation after taxol treatment in NIH3T3 cells involves the elongation factor (eEF)2.
Topics: Adaptor Proteins, Signal Transducing; Adenosine Triphosphate; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Calpain; Carrier Proteins; Caspase 3; Caspase Inhibitors; Cell Cycle Proteins; Eukaryotic Initiation Factor-4E; Eukaryotic Initiation Factors; Mice; NIH 3T3 Cells; Paclitaxel; Peptide Elongation Factor 2; Phosphoproteins; Phosphorylation; Protein Biosynthesis; RNA, Messenger | 2007 |